Clinical trials
Observational Macular Degeneration trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 5 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 3 |
| Complement Therapeutics | 2 |
| Medical University of Vienna | 2 |
| Moorfields Eye Hospital NHS Foundation Trust | 2 |
| OKKO Health | 2 |
| University of Southampton | 2 |
| Association for Innovation and Biomedical Research on Light and Image | 1 |
| Astellas Institute for Regenerative Medicine | 1 |
| Aston University | 1 |
| Brighton and Sussex University Hospitals NHS Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Macular Degeneration | 28 |
| Geographic Atrophy | 4 |
| Retinal Diseases | 4 |
| Vision Disorders | 3 |
| Anetoderma | 2 |
| Cataract | 2 |
| Retinal Degeneration | 2 |
| Amblyopia | 1 |
| Anxiety Disorders | 1 |
| Atrophy | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.